Showing 76 - 89 out of 89 results
Heart and Vascular
Heart Failure
RELIVE Trial- Randomized Evaluation of Less Invasive Ventricular Enhancement
Cancer
Breast Cancer
Real-world Evaluation of Patient Outcomes and Experiences With Ribociclib Early Adopters: A Hybrid Study With Prospective Patient-reported Outcomes and Retrospective Clinical Chart Review.
Heart and Vascular
Aortic Valve
RESTORE Study (REdo tranScatheter aortic valve replacement for Transcatheter aOrtic valve failuRE)
Cancer
Breast Cancer
A Phase III, Multisite, Randomized, Double-Blind Trial of BNT327 in Combination With Chemotherapy Versus Placebo With Chemotherapy in Patients With Previously Untreated Locally Recurrent Inoperable or Metastatic TNBC Determined Ineligible for PD(L)1 Therapy Based on PD-L1 Negative Disease
Neurosciences
Neurology | Ischemic Stroke
Statins use in intracerebral hemorrhage patients
Heart and Vascular
Aortic Stenosis
Siegel Transcatheter Aortic Valve Replacement in patients with symptomatic severe aortic stenosis
Cancer
Liver Cancer
An Interventional Open-label Phase 1b/2 Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of PF-08634404 as Monotherapy and Combination Therapy in Adult Participants With Unresectable Locally Advanced or Metastatic Hepatocellular Carcinoma
Heart and Vascular
Heart Failure | Left Ventricular Assist Device (LVAD)
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients with Advancing Heart Failure
Heart and Vascular
Interventional Cardiology
A Pivotal, Prospective, Multicenter, 2:1 Randomized, Double Blind, Controlled Study Comparing the THerapeutIc IntraVasculaR Ultrasound (TIVUS™) REnal Denervation System vs. Sham for the Adjunctive Treatment of Hypertension (The THRIVE Study)
Heart and Vascular
Cardiomyopathy
An AAV Gene Therapy Trial of AFTX-201 in Adults With BAG3-Associated Dilated Cardiomyopathy (DCM)
Heart and Vascular
Hypertension
The Global Paradise® System US Post Approval Study
Cancer
Cancer Screening
The Vanguard Study: Testing a New Way to Screen for Cancer
Cancer
Breast Cancer
A Randomized, Open-Label, Phase 3 Study of Fulvestrant and CDK4/6 Inhibitors With or Without Gedatolisib as First-Line Treatment in Patients With HR-Positive and HER2-Negative Advanced Breast Cancer
Heart and Vascular
Electrophysiology
The WiSE®-UP Registry (The WiSE System Utilization & Performance Registry)
Saint Luke's is committed to improving your experience. If you have questions, please call Saint Luke's Concierge at 816-932-5100, Monday–Friday, 7 a.m.–5 p.m. In case of emergency please call 911.